Enfusion Inc. (ENFN)
Delisted
17 Apr 2025
NYSE NYSE Primary $
10. 76
-0.04
-0.3704%
$
955.99M Market Cap
132.86 P/E Ratio
- Div Yield
2.46M Volume
0.22 Eps
$ 10.8
Previous Close Day Range
10.74 10.87
Year Range
7.83 11.8
Want to track ENFN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Enfusion: Expectations Of Faster Growth And Higher Margins Justify A Buy Rating
Enfusion targets to grow its top line at a faster pace by optimizing its customer mix. Positive operating leverage and an increase in operating efficiency will support higher EBITDA margins for Enfusion. I expect ENFN to achieve revenue growth acceleration and profitability improvement in the future, and this supports a Buy rating.
Seekingalpha | 2 years ago
